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Abstract
Cell-derived microvesicles (MVs), recognized as important components of cell-cell communication, contain mRNAs, miRNAs,
proteins and lipids and transfer their bioactive contents from parent cells to cells of other origins. We have studied the effect
that MVs released from embryonic stem cells (ESMVs) have on retinal progenitor Mu¨ller cells. Cultured human Mu¨ller cells
were exposed to mouse ESMVs every 48 hours for a total of 9 treatments. Morphological changes were observed by light
microscopy in the treated cells, which grew as individual heterogeneous cells, compared to the uniform, spindle-like
adherent cellular sheets of untreated cells. ESMVs transferred to Mu¨ller cells embryonic stem cell (ESC) mRNAs involved in
the maintenance of pluripotency, including Oct4 and Sox2, and the miRNAs of the 290 cluster, important regulators of the
ESC-specific cell cycle. Moreover, ESMV exposure induced up-regulation of the basal levels of endogenous human Oct4
mRNA in Mu¨ller cells. mRNA and miRNA microarrays of ESMV-treated vs. untreated Mu¨ller cells revealed the up-regulation of
genes and miRNAs involved in the induction of pluripotency, cellular proliferation, early ocular genes and genes important
for retinal protection and remodeling, as well as the down-regulation of inhibitory and scar-related genes and miRNAs
involved in differentiation and cell cycle arrest. To further characterize the heterogeneous cell population of ESMV-treated
Mu¨ller cells, their expression of retinal cell markers was compared to that in untreated control cells by
immunocytochemistry. Markers for amacrine, ganglion and rod photoreceptors were present in treated but not in control
Mu¨ller cells. Together, our findings indicate that ESMs induce de-differentiation and pluripotency in their target Mu¨ller cells,
which may turn on an early retinogenic program of differentiation.
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Introduction
Microvesicles (MVs), a heterogeneous population of vesicles
(30nm to 1mm in diameter) that are released into the intercellular
environment by the majority of cells, are increasingly recognized
as important components of cell-cell communication, and as being
capable of exerting pleiotropic effects on the surrounding cells
[1,2]. MVs were first identified in human plasma [3], and until
recently believed to be inert cellular debris. They are released
either by direct budding from the cell plasma membrane as
shedding vesicles or as exosomes that originate in the endosomal
membrane compartment and are extruded from the cell surface of
activated cells [1,2,4,5]. Our group and others have demonstrated
that MVs contain mRNA, miRNA, proteins and lipids and that
they can transfer their contents to cells of other origins, acting as
‘‘physiologic liposomes’’ [6,7]. MVs may affect their target cells by
stimulating them directly via surface-expressed ligands, by trans-
ferring surface receptors between cells, or by transferring genetic
information from the parent to the target cells [1,7,8]. MVs
derived from adult progenitor cells of several tissues have been
shown to induce not only stem cell differentiation along the
lineages of the MV donor [8–10] but also the endogenous
regenerative capacity of those tissues [11], helping to repopulate
and repair, for example, injured liver [9], lung [10] and kidneys
[1,12].
Embryonic stem cell-derived MVs (ESMVs) are enriched in
mRNAs for early transcription factors and miRNAs important for
embryonic stem cell (ESC) pluripotency [6,13]. ESMVs have been
shown to promote the survival and improve the expansion of
hematopoietic progenitor cells [7]. These findings suggest that by
transfer of stem cell-specific molecules, ESMVs can induce the
activation of endogenous, adult, quiescent progenitor cells in-
creasing their pluripotency and possibly their ability to repair
damaged tissues. While evidence of the protective and pro-
regenerative effects of MVs on whole tissues is increasing, no data
on the effects of ESMVs on individual progenitor cell populations
has been obtained to date. In this study, we investigated the effects
that ESMVs have on the morphology, mRNA and miRNA
expression of cultured retinal progenitor Mu¨ller cells.
Mu¨ller cells, the analogues of radial glia in the retina [14], are
emerging as likely candidates for retinal progenitor cells [15–18].
They meet several of the requirements to be considered progenitor
cells, including the ability to differentiate along multiple retinal
lineages such as photoreceptors and inner retina neurons [15–19].
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e50417
Mu¨ller glia are the source of near complete retinal restoration in
fish [20], and of limited retinal regeneration in chicken
[15,17,21,22]. Recently, there have been reports of Mu¨ller glial
cell proliferation and differentiation into cells of retinal lineage in
adult rodents after injury [16,23]. While Mu¨ller cells are activated
in the injured retina with some regenerative success, functional
retinal recovery has not yet been achieved [24]. Identification of
factors that induce Mu¨ller cells to de-differentiate, enter the cell
cycle, and differentiate along retinal neural lineages may lead to
novel therapy development for retinal degenerative diseases. Our
study explored the tantalizing possibility of employing ESMVs as
agents that activate the regeneration program in Mu¨ller cells. Here
we demonstrate that ESMVs added to the cultures of retinal
progenitor Mu¨ller cells induce in them morphological changes
towards a more de-differentiated phenotype and cause selective
transfer of ESC mRNA and miRNA, resulting in induction of
embryonic and early retinal genes. We also show that ESMV
treatment induced a transcriptome change in Mu¨ller cells,
suggestive of de-differentiation and activation of a retinal re-
generation program. We observed the up-regulation of pluripo-
tency and early retinal genes, genes involved in retinal protection
and inducers of retinal regeneration, as well as multiple
extracellular matrix (ECM) modifying molecules that create
a permissive environment for retinal regeneration, and down-
regulation of genes promoting differentiation and inhibitory ECM
and scar components. Moreover, we show that ESMVs induced
a shift in the miRNA transcriptome of Mu¨ller cells towards a de-
differentiated progenitor state. Together, these results suggest that
ESMVs hold future promise as therapeutic agents to activate the
retina’s endogenous regenerative potential.
Results
ESMV treatment induces morphological changes in
Mu¨ller cells in culture
ESMVs isolated from the supernatant of cultured mouse ESCs
were added to human Mu¨ller cell cultures every 48 hours for
a total of 9 treatments. Although the treated and non-treated
(control) cultures were initiated from the same passage, number of
cells, and confluence level of Mu¨ller cells, morphological
differences became evident between control and ESMV-exposed
cells as early as after the first treatment (Figure 1). In contrast to
control cells that grew as uniform, spindle-like, adherent cellular
sheets characteristic of typical Mu¨ller cells cultures (Figure 1A), as
ESMV treatments progressed, the exposed Mu¨ller cells increas-
ingly grew as individual heterogeneous cells, demonstrating
decreased cell-cell adhesion, presence of cells with multiple
processes, stellate cells, multinucleated cells, and cells with
unilateral boutons and extensive processes (Figures 1 B, and C).
Often, the nuclei of ESMV-treated cells were enlarged, many
demonstrating visible metaphase plates. Cell count comparison
between ESMV-treated and control cultures did not reveal
significant decline in the overall number of cells in the treatment
group (Figure 1D).
ESMVs selectively transfer to Mu¨ller cells mRNA and
miRNA transcripts known to induce pluripotency and the
expression of embryonic and early retinal genes
We had previously demonstrated the presence of pluripotency
factors such as the mRNAs encoding Oct4, Nanog and Gata-4 as
well as miR-292, -294 and -295 in mouse ESMVs using qRT-PCR
[6]. We then examined the level of these transcripts as well as of
Sox2, Klf4 and Lin28 mRNAs in 4 independent ESMV populations
and found that they are abundant and present in comparable
amounts (unpublished results). We now investigated whether
ESMVs transfer these pluripotency-inducing mRNAs and miR-
NAs to Mu¨ller cells and whether their expression as well as that of
embryonic and early retinal genes is altered within Mu¨ller cells at
8, 24, and 48 hours post-ESMV exposure. With the use of qRT-
PCR and species-specific primers we were able to distinguish
between the transfer by ESMVs of mRNA transcripts from mouse
ESCs and the induction by ESMVs of endogenous transcripts of
human Mu¨ller cells. While mouse Oct4 and Sox2 mRNAs were
transferred from ESMVs and remained elevated in Mu¨ller cells
48 hours after ESMV treatment (Figure 2, A and B), no Nanog
transfer was observed at any time point post-treatment (Figure 2C),
suggesting that ESMVs transfer genetic information by a selective
mechanism.
Human Oct4 mRNA in ESMV-treated Mu¨ller cells was
increased 3-fold as early as 8 hours post-ESMV exposure and
remained elevated for the next 40 hours (Figure 2D), indicating
that the induction of the endogenous Oct4 mRNA of Mu¨ller cells
by ESMVs begins shortly after exposure and persists for days. The
levels of Pax6 and Rax mRNAs, which encode transcription factors
known to be expressed throughout retinogenesis by multipotent
retinal progenitor cells [25,26], were found elevated 8 hours post-
ESMV exposure and persisted at the 48 hour time point (Figure 2,
E and F).
That the results above were specific to the ESMV treatment was
corroborated by using two other controls in addition to the Mu¨ller
cells that had not been exposed to ESMVs: a) the residue from
equal volume of ESGRO Complete PLUS medium as that used in
the isolation of ESMVs from ESCs, after ultracentrifugation at
200,000 g for 3.5 hours, was re-suspended in Mu¨ller cell culture
medium and then incubated with Mu¨ller cell cultures for 8, 24 or
48 hours to determine whether it could modify the expression of
the specific mRNAs; and b) The same volume of medium from
a culture of mouse embryonic fibroblasts (MEFs) as that used in
the isolation of ESMVs from ESCs was processed as in a) to see if
microvesicles released by cells different from ESCs could also
change the expression of the studied mRNAs. After qRT-PCR
with the specific primers, the levels for mouse Oct4 and Sox2 as well
as human Oct4, Pax6 and Rax mRNAs were the same in Mu¨ller
cells not exposed to ESMVs and in Mu¨ller cells treated with the
ESGRO medium components or with the MEF conditioned
medium. These results demonstrate that only incubation with
ESMVs changes the specific mRNA levels in Mu¨ller cells.
miRNAs, small noncoding RNAs, are important regulators of
gene expression and maintenance of ESC pluripotency and cell
fate determination [27–29]. It has been demonstrated that ESMVs
are highly enriched in miRNAs [6], including ESC-specific
miRNAs of the 290-cluster, known to be involved in maintenance
of ESC pluripotency [28]. We hypothesized that the transfer of
miRNAs is likely to be one of the mechanisms by which ESMVs
influence gene expression in Mu¨ller cells. Using qRT-PCR, we
tested for the presence of miRNA-292 and -295 in Mu¨ller cells at
8, 24, and 48 hours post-ESMV treatment, using U6 snRNA,
a small nuclear RNA ubiquitous in mammalian cells, as
normalizer. Since mature miRNA transcripts are very short,
a strategy that uses a stem-loop RT primer was used [6]. To avoid
confounding levels of such small transcripts by enrichment
methods for ESMVs, we used the same total RNA samples used
earlier for mRNA transfer studies to assay miRNA transfer. Both
miRNA -292 (Figure 3A) and 295 (Figure 3B) were found to
transfer efficiently to Mu¨ller cells and persist for 48 hours post-
treatment, indicating that miRNAs are not degraded, possibly
playing a role in gene expression alterations of Mu¨ller cells.
ESMVs and Gene Expression Changes in Mu¨ller Cells
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Genome-wide analysis of gene expression changes
induced in Mu¨ller cells by ESMV exposure
We compared the transcriptional response of Mu¨ller cells after
8, 24, and 48 hours of ESMV exposure with the transcriptome of
control Mu¨ller cells cultured for the same number of hours by
hybridization of cDNA from 3 (8 and 24 hours) and 2 (48 hours)
independent biological samples of control and ESMV-treated
Mu¨ller cells, each in triplicate, to Agilent human 8X60K cDNA
arrays (Agilent, Santa Clara, CA, USA). The RMA algorithm was
used for data normalization [30]. The minimum thresholds for
selecting significant genes were set at $3 log2-transformed fold-
change and FDR-corrected p,0.001. Genes that met both criteria
simultaneously were considered significantly changed.
Known marker genes of Mu¨ller glia were detected in the
microarrays [20,31,32]: glutamine synthetase (Glu1), clusterin
(Clu), dickkopf homolog 3 (Dkk3), aquaporin 4 (Aqp4), S100
calcium binding protein A16, Apolipoprotein E (ApoE), Vimentin
(VIM), and glial fibrillary acidic protein (GFAP).
1894 genes were differentially expressed at all 3 time points
post-ESMV treatment, with 801 genes up- and 1093 genes down-
regulated (Figure 4A). Tight clustering of genes in ESMV-treated
vs. control Mu¨ller cells was observed, with treated cells sharing
a similar gene expression profile over a wide range of genes
(Figure 4B). More than 60% of the gene expression changes
occurred by 8 hours post-treatment. 1444 genes were up- and
1878 genes were down-regulated at 8 hours, 1623 genes were up-
and 1828 genes were down-regulated at 24 hours, and 1711 genes
were up- and 1907 genes were down-regulated at 48 hours post-
ESMV treatment. The majority of gene expression changes (95%)
occurred by 24 hours, with only 624 genes unique to the 48-hour
time point (Figure 4A).
Figure 1. ESMVs induce morphological changes in Mu¨ller cells. (A) Untreated Mu¨ller cells growing as homogeneous, bipolar, spindle-like
adherent cell ‘‘sheets’’ (B) Mu¨ller cells post 9 ESMV treatments, growing as morphologically heterogeneous individual cells, some with multiple
cellular processes, others with enlarged nuclei or multinucleated, many having visible metaphase plates and numerous stellar-shaped. (C) Collage of
individual cells morphologically unique to the ESMV treatment group. (D) Timeline of the morphological changes that take place in Mu¨ller cells after
ESMV treatments. As Mu¨ller cells cultures progressively received more ESMV treatments, cells with apical boutons and varied morphologies appeared.
The control group did not exhibit morphological changes, remaining a uniform culture of homogeneous bipolar cell sheets. ESMV-treated (T) and
control (C) cells were counted after each treatment and the ratio of treated to control cells calculated (T/C 6 S.E.M.).
doi:10.1371/journal.pone.0050417.g001
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Gene ontology (GO) analysis revealed that many of the genes
differentially regulated at 24 and 48 hours post-treatment
belonged to the transcription factor families, genes involved in
retinogenesis, organ and organismal development, and genes
encoding cell-cell signaling molecules, receptors involved in
morphogenesis, multiple cytokines and immune response genes.
Grouped by functional category (Figure 5A), ESMV-treated
Mu¨ller cells differentially expressed multiple genes involved in
cellular movement and extracellular matrix composition, in-
flammation, cellular growth and proliferation, tissue response to
injury, molecular transport, energy metabolism, embryonic de-
velopment, cell survival, DNA replication, and genes involved in
ophthalmic diseases (Table S1). Many of the 1894 genes
differentially expressed in ESMV-treated Mu¨ller cells at all time
points have been linked, among others, to the following canonical
signaling pathways: communication between innate and adaptive
immune cells, G-protein coupled receptor signaling, vitamin D
receptor and retinoic acid X receptor activation (important in the
development of neural retina [33]), IL6 signaling (known retino-
protective pathway [34]), neuregulin signaling (a pathway known
to play a role in promoting retinal neuron survival and neurite
outgrowth in developing retina [35]) and axonal guidance
(Figure 5B).
Among the up-regulated genes were pluripotency genes Oct4,
Lin28, Klf4, and LIF, early retinal genes Bmp7, Olig2, FoxN4, Dll1,
Pax6, and Rax, genes with known retinal protective properties (IL6,
CSF2) and inducers of retinal regeneration (Fgf2, IGF2, GDNF), as
well as multiple extracellular matrix modifying molecules, such as
the gene for Matrix metalloproteinase 3 (MMP3), that are known
to create permissive environment for tissue remodeling. Among
Figure 2. ESMVs transfer embryonic stem cell mRNA to Mu¨ller cells and induce the expression of endogenous embryonic
transcripts in Mu¨ller cells. Using qRT-PCR, embryonic stem cell-specific mRNA transfer was assayed with mouse-specific Oct4 and Sox2 primers,
while induction of endogenous Mu¨ller cell genes was detected using human Oct4, Pax6, and Rax primers. Bar plots show the fold change in
expression for the embryonic stem cell-specific [Oct4 (A), (D) and Sox2 (B)] and early retinal [(Pax6 (E) and Rax (F)] transcripts in Mu¨ller cells exposed
for 8, 24, and 48 hours to ESMVs, compared to those in control Mu¨ller cells that received medium changes only (light green bars). No Nanog transfer
was observed (C). Gapdh was used as a loading control for qRT-PCR. Error bars represent S.E.M. Student’s t-test, performed to assay the difference
between experimental and control Mu¨ller cells groups, showed that these differences were significant, all of them with p-values,0.05, except for
Nanog mRNA (C).
doi:10.1371/journal.pone.0050417.g002
Figure 3. ESMVs transfer ESC miRNA to Mu¨ller cells. Bar plots showing the fold change in the levels of ESC-specific miRNA 292 (A) and miRNA
295 (B) in Mu¨ller cells at 8, 24, and 48 hours after ESMV treatment. The levels of both miRNAs tested were persistently elevated at 48 hours post
transfer, indicating that these miRNAs are not degraded for days after transfer. The y-axis correspond to the fold changes between the treatment and
control (light green) groups of Mu¨ller cells. Error bars represent S.E.M. Significant differences between experimental and control groups were
determined by Student’s t-test. All p-values were ,0.01.
doi:10.1371/journal.pone.0050417.g003
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the down-regulated genes were those promoting differentiation,
such as DNMT3a and GATA4, inhibitory extracellular matrix
components such as Aggrecan, Heparan Sulfate, and Tenascin, and
inhibitory scar tissue components such as GFAP and chondroitin
sulfate proteoglycans. Expression changes in these genes were more
pronounced at 24 and 48 hours post-treatment. While the
expression of c-Myc, a well-characterized pluripotency-inducing
factor [36], was detected in Mu¨ller cells, it remained unchanged
throughout the course of ESMV treatments. Interestingly, Hes1,
Notch 1, Notch2, and NeuroD1, genes believed to regulate cell cycle
re-entry, de-differentiation, and activation of retinal stem cell
phenotype in Mu¨ller cells [18], were most up-regulated at 8 hours
post-ESMV treatment, with levels remaining increased over
baseline, but declining at other time points. The expression of
EGFR, a gene involved in driving retinal progenitors towards
Mu¨ller glial fate during retinogenesis [20] was down-regulated at
all three time points. The observed changes in Mu¨ller cells’
transcriptome induced by ESMV treatments suggest a shift
towards a more de-differentiated state, possibly through the
activation of the proliferative and regenerative programs of these
cells.
Additionally, microarray data analysis revealed the up-regula-
tion of several genes encoding markers of various retinal lineages
in Mu¨ller cells exposed to ESMVs, including those for calbindin 1,
a marker of horizontal and amacrine retinal neurons, syntaxin 1a,
a marker of amacrine cells, and rhodopsin, a marker of rod
photoreceptors. The expression of calbindin 1 was highest
48 hours post-ESMV, while the expression of rhodopsin and
Figure 4. Microarray analysis of gene expression changes in Mu¨ller cells post-ESMV treatment. (A) Venn diagram of gene expression
changes in ESMV-treated vs. control Mu¨ller cells at 8, 24, and 48 hours post ESMV exposure. The expression of 1894 genes was altered by ESMV
treatment at all three time-points. There was significant overlap in differentially regulated genes between 8 and 24 hours (192) and 24 and 48 hours
(853) post-treatment. The majority of gene expression changes occurred by 24 hours post-ESMV exposure. (B) Heat map representation of heirarchal
clustering of 16 samples based on the 1894 probes found to be differentially regulated in the Mu¨ller cells post-ESMV treatment vs. control (p-
value,0.001 and a minimum of 3-fold difference in expression). These transcripts were clustered with conventional Heat map analysis, with red
representing up- and blue representing down-regulation; rows represent the samples and columns represent the genes.
doi:10.1371/journal.pone.0050417.g004
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syntaxin 1a was increased at all tested time points. These findings
suggest that subsets of de-differentiating Mu¨ller cells may trans-
differentiate into cells of other retinal lineages.
Confirmation of ESMV-induced gene expression changes
We verified with qRT-PCR of RNA from Mu¨ller cells subjected
to ESMV treatment for 24 and 48 hours the expression profiles of
a subset of genes involved in the processes of de-differentiation
(Cyclin D2, BMP7), retinal protection (IL6, IGF2), repair and tissue
remodeling (MMP3), as well as genes involved in scar formation
(GFAP) and inhibition of ECM components (Aggrecan), all of which
were significantly altered in the ESMV-treated group on the
microarrays. These time points were chosen because the majority
of changes in the expression of genes involved in retinal protective
and regenerative processes were observed within 24 and 48 hours.
All tested genes demonstrated the same pattern of regulation as
observed in microarrays (Figure 6). In particular MMP3 mRNA,
which encodes a matrix metalloproteinase that up-regulates in
newt adult organ repair, including retina, and facilitates the
integration into the retina of transplanted photoreceptors when
present at elevated levels [37,38], was found strongly up-regulated
in microarrays and qRT-PCR experiments, as was IL6 mRNA; its
expressed interleukin has been demonstrated to have a protective
effect on inner retina neurons [39]. On the other hand, the
Aggrecan gene, which encodes a chondroitin sulfate proteoglycan
required for normal glial cell differentiation and development [40]
was among the genes down-regulated in microarrays and qRT-
PCR studies, as was GFAP, a gene that when deleted from the
mouse genome improves retinal transplant integration [37].
Genome-wide analysis of miRNA expression changes
induced in Mu¨ller cells by ESMV exposure
In addition to their increasing recognition as important
regulators of mammalian gene expression, cell cycle regulation,
and cell fate determination, recent evidence implies that miRNAs
play a role in retinogenesis, regulating retinal progenitor cells’
progression from early to late stages and their differentiation
towards various retinal cell lineages [41]. We hypothesized that
miRNAs delivered to Mu¨ller cells by ESMVs may alter the
miRNA and mRNA expression profiles of Mu¨ller cells and shift
these cells towards a de-differentiated state. We used a portion of
the total RNA used in the microarray studies described above to
examine the global miRNA transcription changes in Mu¨ller cells
post-ESMV treatment in parallel with global mRNA expression
changes. Exiqon mercury LNA microRNA Arrays, which include
927/648/351 human/mouse/rat miRNAs as well as 438 miRPlus
miRNAs were used in our studies. The obtained raw miRNA data
were normalized using a combination of housekeeping miRNAs
and invariant miRNAs. The threshold to select miRNAs with
significantly altered expression was set at $3 fold change and
FDR-corrected p,0.05. 720 miRNAs were detected in Mu¨ller
cells. Overall, the expression of 173 miRNAs was altered by
ESMV treatment; 25 of these miRNAs were differentially
expressed at all three time points tested, with 11 up- and 14
down-regulated (Figure 7). 25 miRNAs were up- and 16 down-
regulated at 8 hours, 32 miRNAs were up- and 28 down-regulated
at 24 hours, and 87 miRNAs were up- and 61 were down-
regulated at 48 hours post-ESMV treatment (Figure 7A). The
majority of alterations in miRNA expression occurred by 48 hours
post-ESMV exposure.
While the exact functions of miRNAs are largely unknown,
processes involving particular miRNAs and miRNA-specific
targets are gaining recognition. Several of the miRNAs previously
noted to be highly expressed in developing retina were up-
regulated in ESMV-treated Mu¨ller cells, including miR-1, miR-
96, miR-182 and miR-183. miRNAs belonging to the 290 cluster
(mir-291b-5p, -292, -294, and -295), the miRNA cluster involved
in the maintenance of ESC pluripotency [42], were up-regulated
and remained increased over 48 hours post-ESMV exposure.
Concurrently, the expression of miR-let-7b and miR-let-7c,
belonging to the miR-let-7 cluster known to inhibit cell cycle
progression and promote cell differentiation [43], decreased post-
ESMV treatment. miR-7, which represses the expression of Yan
protein and promotes photoreceptor differentiation [44], as well as
miR-125-2b, highly abundant in adult retina [45], were down-
regulated over 48 hours post-ESMV treatment. Among the
miRNAs strongly up-regulated at all three time points tested were
miR-133a (increased 30-fold) and miR-146a (increased 37-fold),
the miRNAs known to promote cell proliferation and inhibit
differentiation of skeletal myoblasts and myogenic stem cells,
respectively, the latter acting via the Notch signaling pathway, the
same pathway known to regulate retinal progenitor differentiation
[22]. Among the miRNAs strongly down-regulated at all tested
times were miR-199b-5p (decreased 70-fold), miR-214 (decreased
37-fold), and miR-143 (decreased 13-fold), known to promote
differentiation of ESCs, neuroblasts, and smooth muscle progeni-
tors, respectively [46,47]. The observed profile of miRNA
expression changes in Mu¨ller cells post-ESMV exposure was
suggestive of de-differentiation, consistent with that observed for
mRNA expression changes.
Confirmation of ESMV-induced miRNA expression
changes
Several miRNAs involved in maintenance of pluripotency (miR-
294, -146a, -133a) and differentiation (miR-199b-5p, -214, -143)
were selected for validation of the microarray results. Total RNA
samples from Mu¨ller cells at 24 and 48 hours post-ESMV
treatment (the time points corresponding to the majority of
miRNA expression changes) and from untreated control cells were
subjected to qRT-PCR using TaqmanH miRNA Assays that
included stem-loop RT primers specific for each miRNA. qRT-
PCR results confirmed the pattern of expression observed by the
microarray screening for all the miRNAs tested (Figure 8).
Immunocytochemical analysis of ESMV-induced Mu¨ller
cell transdifferentiation
To further characterize the morphologically heterogeneous cell
population observed in the cultures of Mu¨ller cells treated with
ESMVs and validate the microarray data, we investigated the
expression of markers of various retinal cell lineages in ESMV-
treated Mu¨ller cells compared to untreated control cells by
immunocytochemistry. In addition to the Mu¨ller cell marker,
Figure 5. Ingenuity pathway analysis of 1894 genes differentially regulated at all tested time points between ESMV-treated and
control Mu¨ller cells at p,0.001 level and fold change$3. In this analysis, genes were tested for significant association in specific cell
functional (A) or canonical cell signaling pathways (B) versus random change association in a total curated database of gene interactions of over
23,900 human, rat and mouse genes by right-tailed Fisher’s exact test (Ingenuity Systems). A. Most significant biological functional groups. B. Most
significant canonical pathways. Significance was assessed by testing the number of genes that were altered by ESMV treatments in a specific pathway
versus total number of genes in this database for that pathway. The orange line indicates the threshold for a significant association, the –log(0.05).
doi:10.1371/journal.pone.0050417.g005
ESMVs and Gene Expression Changes in Mu¨ller Cells
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glutamine synthetase (GS), we observed immunoreactivity to
Gad67, a marker of amacrine and horizontal cells (Figure 9, A and
C), NeuN, a marker of amacrine and retinal ganglion cells
(Figure 9, G and I), Brn3a, a marker of retinal ganglion cells
(Figure 9M), and syntaxin 1a, a marker of amacrine cells
(Figure 9O) in small populations of ESMV-treated Mu¨ller cells.
None of these markers were present in the untreated control
cultures. Interestingly, immunoreactivity to rhodopsin, a marker of
rod photoreceptors, was seen primarily localized in cytoplasmic
granules in a very small number of treated cells (Figure 9Q). No
immunoreactivity to Parvalbumin, a bipolar and horizontal cell
marker, or Vesicular Glutamate Transporter 1, a marker for
bipolar and photoreceptor cell terminals, was found. No staining
was observed when primary antibodies were omitted. Our data
suggest that ESMV treatment induces transdifferentiation of
Mu¨ller cells into cells of retinal neural lineage, mainly towards
amacrine and retinal ganglion cells, but not horizontal or bipolar
cells. The very limited expression of rhodopsin post-ESMV
exposure also suggests that ESMV treatment may induce at least
a partial activation of genes of photoreceptor lineage.
Discussion
ESMVs selectively transfer mRNA, microRNA, and proteins
from their parent cells to recipient cells, likely altering gene
expression, epigenetic state, and ultimately, cell fate of their
recipients. We studied the effects of ESMVs on the morphology,
mRNA and miRNA expression of retinal Mu¨ller cells. These cells
have been shown to re-enter the cell cycle and regenerate all
retinal layers in lower vertebrates [48,49] and to exhibit pro-
genitor-like gene expression and activity in mammalian retinas,
generating retinal neurons, including photoreceptors, in vitro
[18,50,51] as well as in vivo after retinal injury, when treated with
a growth factor regimen [16,17,22,23]. However, this response has
been limited, likely due to the inhibitory effects of the microen-
vironment of the adult mammalian retina and, possibly, in-
sufficient pro-regenerative stimulation. This study is the first to
demonstrate the morphological, mRNA and miRNA expression
changes towards a more de-differentiated phenotype induced by
ESMV treatments in cultured Mu¨ller cells of the adult human
retina. Moreover, we also observed changes in the expression of
ECM building blocks, inhibitory scar tissue components, and
ECM-modifying enzymes, suggestive of a shift in cellular
microenvironment towards a more permissive state for tissue
regeneration. Thus, our results possibly indicate that ESMVs may
modify cell fate as well as cellular microenvironment toward
a more de-differentiated, pro-regenerative state.
We demonstrated before [6] the transfer by ESMVs of mRNAs
encoding transcription factors important for maintenance of ESC
pluripotency, Oct4 and Sox-2, to fibroblasts and other ESCs and
now show that ESMVs also transfer these mRNAs to human
Mu¨ller cells, Moreover, there was an up-regulation of endogenous
Oct4 mRNA of Mu¨ller cells following ESMV exposure. The
greatest levels of Oct4 mRNA, both transferred and endogenous,
were observed at 8 hours post-ESMV, but both persisted for
48 hours, suggesting that Oct4 mRNA was utilized in these cells
over time. The lack of Nanog mRNA transfer, despite its
abundance in ESMVs, suggests that there exists a selection
mechanism to direct the genetic transfer, or that only a subset of
mRNAs transferred are retained by the recipient cells, while the
rest are rapidly degraded. ESMVs transferred to Mu¨ller cells
miRNAs 292 and 295, the ESC cell cycle-regulating miRNAs
involved in maintenance of ESC pluripotency, which, when
introduced into somatic cells along with the Klf4, Oct4 and Sox2
genes promote the somatic cell reprogramming towards pluripo-
tency [42]. The persistence of these transferred miRNAs for
48 hours suggests that they are utilized by the Mu¨ller cells, and
Figure 6. qRT-PCR analysis confirmed gene expression changes of microarray-identified genes in Mu¨ller cells at 24 and 48 hours
post-ESMV treatment compared to untreated controls. Each bar represents the relative abundance of the genes tested in ESMV-treated vs.
untreated Mu¨ller cells. Error bars represent S.E.M.; all samples were tested in at least three biological replicates, run in triplicates; Student’s t-test was
used to assess significant differences between experimental and control groups. *, p,0.00001; X, p,0.0005; and o, p,0.001. Gapdh was used for
normalization.
doi:10.1371/journal.pone.0050417.g006
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likely facilitate the induction of embryonic pluripotency-promoting
transcription factors, such as Oct4 [28]. Our observation of the
transfer of pluripotency-inducing mRNAs and miRNAs by
ESMVs to Mu¨ller cells supports the hypothesis that ESMVs may
serve the function of physiologic liposomes, delivering the de-
differentiation signals to the quiescent progenitor cells. In light of
the recent demonstrations of mesenchymal and bone marrow stem
cells augmenting regeneration of cardiac and vascular tissue after
ischemic injuries [52] and the observations of microvesicles
derived from several adult stem cell populations augmenting the
repair of renal, hepatic, and lung tissues, the microvesicle-
mediated transfer of pluripotency-inducing mRNAs and miRNAs
observed in our study offers an insight into the paracrine
mechanim by which stem cells may be able to augment tissues’
endogenous regenerative capacity, bypassing the need for tissue
engraftment.
Pax6 is among the earliest transcription factors to appear in the
retina and it is involved in the entire process of retinogenesis [26];
it is a marker of neurogenic radial glia in the adult CNS [53] and
of retinal progenitor cells [25]. A subset of adult Mu¨ller cells has
been demonstrated to express low levels of Pax6, corroborating the
recognition of these cells as adult retinal progenitors [17]. We
observed an increase in Pax6 mRNA levels in our Mu¨ller cell
samples beginning at 8 hours post-ESMV exposure, progressively
increasing to more than 5-fold 48 hours after treatment. Similarly,
the expression level of the Rax mRNA – also one of the first to
appear homeobox transcription factors that defines the eye field
during early development and is involved in determination of
Figure 7. Microarray analysis of miRNA expression changes in Mu¨ller cells post-ESMV treatment. (A) Venn diagram of miRNA expression
changes in ESMV-treated vs. control Mu¨ller cells at 8, 24, and 48 hours post-ESMV treatment. The expression of 25 miRNAs was altered at all three
time points tested. The majority of the miRNA expression changes occurred at 48 hours post-ESMV, progressively increasing from 41 miRNAs at
8 hours, to 60 miRNAs at 24 hours, and 148 at 48 hours. (B) Heat map representation of hierarchal clustering of 16 samples based on 25 miRNA
probes differentially regulated in ESMV-treated vs. control Mu¨ller cells at all times tested. (p,0.05, minimum 3-fold difference in expression). Each row
represents a single sample, and each column-a single miRNA. The red or blue color represents relatively high or low expression, respectively. The two
main groups of the dendrogram, labeled EXPT and CTR, separate treated vs. control groups of Mu¨ller cells.
doi:10.1371/journal.pone.0050417.g007
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photoreceptor cell fate – was strongly (.100-fold) induced 8 hours
post-ESMV treatment, with high, albeit declining levels remaining
40 hours later. Both Pax6 and Rax direct retinal cell differenti-
ation during embryogenesis [54] and during the derivation of
retinal cell types from ESCs and retinal progenitor cells [55,56].
The observed expression changes suggest that ESMV-treated
Mu¨ller cells shift towards a more de-differentiated state, assuming
an early retinal progenitor phenotype and possibly reactivating the
developmental program involved in retinogenesis. Re-activation of
the quiescent resident progenitors in the retina opens the
possibility of retinal repopulation without the need for utilization
of ESC-derived retinal layers. Since retinal resident progenitors
are epigenetically programmed to assume the retinal lineage, the
transdifferentiation of these cells will offer a safer, less invasive
alternative to cell transplantation.
ESMV treatment induced a robust global gene expression
change in Mu¨ller cells, activating a distinct transcriptome, which
differed markedly from that of untreated cells. Using stringent
statistical parameters to select a set of genes that changed
expression significantly post-ESMV treatment, we identified
1894 distinct genes common to all of the post-treatment groups
(8 hours, 24 hours, and 48 hours). The analysis of the post-
treatment transcriptome showed enrichment in the embryonic
pro-pluripotency genes, early retinal genes, retinoprotective genes,
and genes known to induce retinal progenitor proliferation and
regeneration, and depletion of pro-differentiation genes and glial
scar markers, consistent with our observations of Mu¨ller cells’
morphological changes towards a more de-differentiated pheno-
type and the results of our initial gene expression studies. Among
the differentially regulated genes were also those coding for ECM
components and ECM-modifying molecules, their changes reflect-
ing a shift from scar formation to a tissue remodeling profile.
These findings indicate that ESMVs are able to alter the gene
expression of the target cells as well as their cellular microenvi-
ronment.
ESMV exposed Mu¨ller cells up-regulate several of the factors
required for generating induced pluripotent cells, including Oct4,
Klf4, and Lin28 [36,49,57] as well as the retinal progenitor
transcriptome. The expression of many of these progenitor genes
increased at different times post-ESMV exposure. For example,
Vsx-1 and Vsx-2, homeobox genes first identified in the peripheral
margin of the adult goldfish retina, were most up-regulated
24 hours post-treatment and their levels declined by 48 hours.
Interestingly, the expression of these genes is restricted to the
Figure 8. qRT-PCR analysis of select miRNAs involved maintenance of pluripotency (294), de-differentiation (133, 146), cell fate
determination and differentiation (199, 214, 143), noted to be differentially expressed on in ESMV-treated vs. control Mu¨ller cells
on miRNA microarrays. Each bar represents the relative abundance of the miRNAs tested in ESMV-treated Mu¨ller cells vs. untreated control cells.
Error bars represent SEM; all samples were tested in at least three biological replicates, run in triplicates; Student’s t-test was used to assess significant
differences between experimental and control groups. *, p,0.00001; X, p,0.0003; &, p,0.001 and o, p,0.005. U6 snRNA was used for
normalization.
doi:10.1371/journal.pone.0050417.g008
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mitotically active adult progenitor cells and declines as the cells
become post- mitotic and begin to differentiate [58]. The
expression of archaete-scute homolog 1 (Ascl1), a gene that is up-
regulated early in the process of regeneration in fish retina and
that when inhibited prevents the regeneration from Mu¨ller cells
[59], was also increased 24 hours post-ESMV. Delta-like 1 (Dll1),
a gene that plays a key role in maintaining a pool of progenitors
during the period of retinogenesis [60], was most up-regulated
8 hours after treatment, with levels steadily declining thereafter.
The expression of FoxN4, a transcription factor that appears at the
earliest stages of retinogenesis and is necessary for induction of
progenitor cell differentiation towards amacrine and horizontal
cells as well as for the proper axonal guidance of retinal ganglion
cells [61], was increased early post-treatment and remained
Figure 9. Confocal photomicrographs of ESMV-treated and control Mu¨ller cells immunostained for markers of various retinal
lineages. In A–L, cells were double stained with Gad67 (amacrine & horizontal cells; green) or NeuN (amacrine and ganglion cells; green) and the
marker of Mu¨ller cells, Glutamine Synthetase (red). (A–C): Gad67-stained ESMV-treated Mu¨ller cells. (D–F) Gad67-stained control Mu¨ller cells. (G–I)
NeuN-stained ESMV-treated Mu¨ller cells. (J–L) NeuN-stained control Mu¨ller cells. The third panel of each row shows the merged first two images. (M)
ESMV-treated and (N) control Mu¨ller cells, stained for Brn3a (green), a marker of retinal ganglion cells. (O) ESMV-treated and (P) control Mu¨ller cells
stained for Syntaxin 1a (green), a marker of amacrine cells. (Q) ESMV-treated and (R) control Mu¨ller cells stained for rhodopsin (green), a marker of rod
photoreceptors. Cell nuclei were labeled with 496-diamidino-2-phenylindole (DAPI, blue). Scale bar 10 mm for all panels. Images show z-axis
projections of 1561 mm in all channels.
doi:10.1371/journal.pone.0050417.g009
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elevated 48 hours later. Prox1, which encodes a transcription factor
expressed in the adult retinal progenitors of teleost fish and in rod
photoreceptor precursors [62], a likely downstream target of
FoxN4 [63], was increased throughout the ESMV treatments,
exhibiting high levels 48 hours post-ESMV. Neurog2, a gene
important in directing retinal progenitors toward neuronal fate,
was up-regulated at 24 hours [64]. As with the eye homeobox
transcription factors Pax6 and Rax, expression of the gene
encoding Bone Morphogenic Protein 7 (BMP7) markedly in-
creased at all post-treatment times. This is a transcription factor
critical for many steps in the progressive development of the eye,
including patterning of the eye field as well as the formation of
retinal pigmented epithelium and retinal ganglion cells [65]. The
Notch pathway plays a pivotal role in maintaining the retinal
progenitor pool and controls the activation of the progenitor
program in Mu¨ller cells [18,23,66]. Several of the Notch pathway
components, including Notch1, Dll1, and Hes1, were up-regulated
in our samples post-ESMV treatment. Taken together, these
findings strongly suggest that ESMV treatments induce de-
differentiation of Mu¨ller cells and activation in these cells of the
retinal progenitor phenotype. Moreover, the activation of early
and late retinal progenitor genes at different times post-ESMV
treatment and the up-regulation of the transcription factors that
direct retinal progenitor differentiation towards multiple retinal
lineages open the possibility that Mu¨ller cells, once induced to
enter the retinal progenitor state by ESMVs, activate a retinogenic
program. Indeed, ESMV treatment induced a small fraction of
Mu¨ller cells to up-regulate the genes for several markers of retinal
amacrine, horizontal, and ganglion cells as well as rhodopsin,
a marker of rod photoreceptors, suggesting transdifferentiation
along several retinal lineages.
Immunocytochemical analysis of ESMV-treated Mu¨ller cells
revealed the presence of cells expressing the marker proteins for
amacrine lineage Gad67 and Syntaxin 1a, cells expressing Brn3a
and NeuroN, markers of retinal ganglion cells, and cells expressing
rhodopsin, a marker of rod photoreceptors. We did not find any
evidence of cells differentiating along the lines of bipolar or
horizontal interneurons. It has been previously demonstrated that
Mu¨ller glial cells are the source of pan-retinal, including neuronal,
regeneration in fish [17,59,67], and to a lesser extent, in post-hatch
chicks, with spontaneous differentiation into amacrine and bipolar
neurons after injury in the latter [22]. Although mammalian
Mu¨ller cells do not spontaneously re-enter the cell cycle after
retinal injury, several groups have reported successful induction of
Mu¨ller cells to enter the cell cycle and generate new amacrine [23]
as well as bipolar and horizontal cells and rod photoreceptors [16]
after treatment of injured retinas with various combinations of
growth factor regimens, including fibroblast growth factor,
epidermal growth factor, retinoic acid, and insulin. Here we
demonstrate that ESMVs induce human Mu¨ller glia to de-
differentiate, turn on an early retinogenic program, and differen-
tiate towards cells of amacrine, ganglion cell, and rod photore-
ceptor lineage in vitro. Future studies will determine whether
ESMVs can efficiently activate retinal resident progenitor Mu¨ller
cells in vivo to augment retinal regeneration after injury. Since the
cellular microenvironment plays a major role in cell fate de-
termination and differentiation in developmental and regenerative
processes, it is possible that, once activated, the resident Mu¨ller
cells may differentiate into cells of other retinal lineages in vivo,
guided by environmental cues.
Another pattern of gene expression changes in Mu¨ller cells post-
ESMV exposure that emerged from our global gene expression
analysis was the increase in genes that play a retinoprotective role
and genes that stimulate retinal repair after injury. ESMV
treatment induced the activation of genes involved in multiple
cytokine pathways and immune response genes, including in-
terleukin signaling, that have been studied extensively as
therapeutic agents in the preservation of retinal ganglion cells
[34]. The expression of IL6, an interleukin found to prevent
photoreceptors from degeneration after retinal detachment [39] as
well as retinal ganglion cell apoptosis in the setting of increased
intraocular pressure [34], was strongly increased (9, 24, and 18-
fold at 8, 24, and 48 hours, respectively) post-ESMV treatment.
Glial- derived neurotrophic factor (GDNF), a growth factor shown
to exert long-term neuroprotection when secreted from Mu¨ller
cells in a rat model of retinitis pigmentosa [68] and increase long-
term ganglion cell survival in glaucoma [69] was also strongly up-
regulated at all times post-ESMV administration. The expression
of neuregulins 1 and 2, known to promote survival and neurite
extension from retinal neurons during retinal development [35],
and FGF2, a growth factor demonstrated to slow down
photoreceptor degeneration in retinitis pigmentosa [70] and
promote retinal regeneration from progenitor cells in Xenopus
[71] were also increased significantly at all times post-ESMV
exposure. These results suggest that ESMVs activate a retino-
protective program in Mu¨ller cells along with activating the
regeneration program.
Together with the genes that dictate Mu¨ller cell fate and
behavior, ESMV treatment induced gene expression changes in
the genes coding for ECM components and ESC modification
molecules. Of note, multiple matrix metalloproteinases (MMP)
were strongly up-regulated at all time points, the most dramatic
up-regulation of more than 200-fold observed in the MMP3
transcript. MMPs are a group of enzymes that degrade inhibitory
ECM components, such as basement membrane molecules,
creating a permissive environment for tissue regeneration and
integration of transplanted cells in the retina [38]. Concurrently,
molecules encoding the ECM components shown to inhibit
neurite outgrowth and retinal regeneration, such as Aggrecan,
Heparan Sulfate, Versican, and Decorin [72], as well as inhibitory glial
scar components, such as GFAP and Tenascin C [37], were strongly
down-regulated. Thus, ESMV treatment directs the changes in
cellular microenvironment towards a more permissive state for
tissue regeneration and rewiring of neural circuitry within the
retina. Elements of extracellular microenvironment normally
present within the retina, subretinal space, and adjacent tissues,
such as the retinal pigment epithelium and Bruch’s membrane,
have a significant effect on cell fate determination of retinal
progenitors [73]. Activation of the resident progenitors within the
damaged retina to de-differentiate and re-enter the cell cycle may
lead to regeneration of those cells lost secondary to retinal damage
in each particular disease or injury.
miRNAs play important roles during embryonic development
as well as in cell fate determination and maintenance of the
differentiated state [13,27,42,74,75]. Distinct patterns of miRNA
expression have been observed at different stages of retinal
development [41,45]. Our results suggest that exposure of human
Mu¨ller cells to ESMVs profoundly alters their miRNA expression
profile, since we observed expression of miRNAs transferred by
the ESMVs as well as changes in their endogenous miRNAs.
Thus, ESMVs seem to induce a distinct change in the epigenetic
state of Mu¨ller cells. For example, several ESC miRNAs of the 290
cluster were transferred from ESMVs and persisted in Mu¨ller cells
for at least 48 hours. The miRNA-290 cluster acts through
multiple mechanisms to promote pluripotency state and oppose
differentiation of ESCs and is down-regulated upon differentiation
and undetectable in adult organs [28]. Moreover, several members
of the miRNA-290 cluster have been shown to enhance the
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efficiency of generation of induced pluripotent stem cells from
adult somatic cells [42]. The transfer of these miRNAs may play
a role in the induction of the endogenous pluripotency genes in
Mu¨ller cells, observed in our microarray analysis, supporting the
shift of Mu¨ller cells towards a progenitor state. In addition, we
observed the up-regulation of endogenous human miR-1, miR-96,
miR-182, and miR-183, the appearance of which marked
progression through early retinal development [45], supporting
the notion that ESMV treatment shifts Mu¨ller cell differentiation
towards an early retinal progenitor stage. The concurrent down-
regulation of the miR-let7 cluster, known to promote differenti-
ation in most cells and de-differentiation when it is inhibited [76],
miR-125, a highly abundant miRNA in adult retina [45], and
miR-7, known to promote photoreceptor differentiation [44] is
consistent with Mu¨ller cell de-differentiation under the influence of
ESMVs. The majority of the miRNA expression changes occurred
by 48 hours post-ESMV exposure, suggesting long-term altera-
tions in the epigenetic state of Mu¨ller cells, and, effectively, in
Mu¨ller cell fate.
Microvesicles have been demonstrated to augment functional
regeneration of hepatic tissue in partially hepatectomized rats [9],
induce bone marrow cells to repopulate radiation-injured lung
[10], and protect and repair acutely and chronically injured
kidneys [12]. In light of these results and the observation that
ESMVs induce de-differentiation and pluripotency of Mu¨ller cells
after prolonged exposure, our data opens the possibility of
employing ESMVs as therapeutic agents to induce and support
the retina’s endogenous regenerative capacity. Future in vivo
studies of the effects of ESMVs on retinal repair will be needed to
explore the mechanism of ESMV action on retinal tissues and
their efficiency in the in vivo induction of retinal regeneration.
Materials and Methods
Ethics Statement
All experiments involving mice were carried out using protocols
approved by the UCLA Animal Research Committee, and in
accordance with the ARVO Statement for Use of Animals in
Ophthalmic and Vision Research.
Mu¨ller Cell Culture
The human Moorfield/Institute of Ophthalmology-Mu¨ller 1
(MIO-M1) cell line, initially derived from postmortem human
neural retina, was established and characterized previously [77].
MIO-M1 cells were maintained as an adherent cell line in
175 cm2 tissue culture flasks for propagation, and in 6-well cell
culture plates for ESMV treatment experiments, in DMEM
medium containing 4500 mg/L glucose, sodium pyruvate and
stabilized L-glutamine (GlutaMAX; Invitrogen, Grand Island,
New York) with 10% vol/vol fetal bovine serum (filtered, heat
inactivated; Gemini Bioproducts, Sacramento, CA) and penicillin/
streptomycin (Invitrogen) in a humidified 37uC, 5% CO2 in-
cubator. Upon reaching confluence, the cells were washed with
phosphate-buffered saline (PBS), detached from the flasks with
trypsin (Invitrogen), washed with complete cell culture medium,
and split into fresh flasks. ESMV treatment experiments were
started when Mu¨ller cells reached 60% confluence. ESMV-
exposed and control Mu¨ller cells were examined after each
treatment using the Leica DM IL LED microscope (Leica
Microsystems, Wetzlar, Germany), and for the determination of
cell number, images of 3-4 fields of view (acquired at 20X
magnification for each well of a 6-well plate of treated and control
cells) were obtained using a Leica DCF295 digital camera. Cells
within each image were individually marked using Adobe
Photoshop (Adobe Systems, San Jose, CA), and then counted.
Cell number per field of view was obtained at each time point for
treatment and control groups and ratios of treated/control cells
were calculated. For morphology studies, Mu¨ller cells were fixed in
100% ethanol for 15 minutes and stained with Harris Hematox-
ylin and Eosin Y (Fisher Scientific, Pittsburgh, PA), dehydrated
with serial ethanol washes, air dried and coverslipped with
ProLong Gold antifade reagent (Invitrogen). The transmitted light
differential interference contrast images were acquired using
a Zeiss Axiovert 135M microscope with a Photometrics CoolSnap
camera (Roper Scientific, Tucson, AZ).
ESC culture and ESMV isolation
ESCs derived from the mouse strain SV129 were expanded
under serum-free and feeder-free conditions in ESGRO Complete
PLUS clonal grade medium supplemented with GSK3b inhibitor
to suppress differentiation (Millipore, Billerica, MA). 3.56106 cells
were plated on gelatin-coated T175 cm2 culture flasks. ESCs were
cultured in a humidified 37uC, 5% CO2 incubator. The growth of
ESCs was monitored microscopically and fresh culture medium
was added daily and collected every 48 hours for ESMV isolation.
ESCs were passaged using ESGRO Complete Accutase (Millipore)
every 48–72 hours to maintain ESC colonies at 80% confluence in
order to maximize ESMV yield while avoiding differentiation of
ESCs. ESC colonies were visually inspected by microscopy on
a daily basis for signs of differentiation and Oct4, Sox2, and Nanog
mRNA expression was assayed by qRT-PCR [mouse specific
primer pairs designed by PrimerQuestSM (Integrated DNA
Technology-DNAsite, San Diego, CA): Oct4: forward-
GCCGGGCTGGGTGGATTCTC, reverse-
ATTGGGGCGGTCGGCACAGG, Nanog: forward-TCCAGAA-
GAGGGCGTCAGAT, reverse-CTTTGGTCCCAGCATT-
CAGG, Sox2: forward-AACAATCGCGGCGGCCCGAGGAG,
reverse-GCCTCGGCGTGCCGGCCCTGCG]. To isolate
ESMVs, the supernatant was collected in 50 ml centrifuge tubes
and spun at 3,500 g for 1 hour at 4uC to pellet debris and
fragmented cells. The supernatant was carefully transferred to an
ultracentrifuge tube and spun at 200,000 g for 3.5 hours in
a Beckman Type 50.2Ti rotor at 4uC to pellet the ESMVs.
ESMV RNA and miRNA content analysis
ESMVs’ total RNA was isolated using the mirVana miRNA
isolation kit, which retains small RNA species (Ambion, Austin,
TX), treated with TURBO DNAse (Ambion) to remove DNA
traces, and examined by RT-PCR for the presence of mouse Oct4,
Sox2, Nanog (primer pairs above), and Klf4, Lin28, and mmu-miR-
292-3p, -294, and -295 (TaqmanH primers) transcripts.
Treatment of Mu¨ller cells with ESMVs
Mu¨ller cells were plated on two 6-well cell culture plates at
16106 cells per well and allowed to reach 60% confluence prior to
initiating ESMV treatments. For these, ESMVs pelleted by
ultracentrifugation of media from 6 T175 cm2 flasks of mouse
ESCs grown in serum free, feeder free conditions, were
immediately resuspended in Mu¨ller cell medium and equal
volume was added to each well of one of the 6-well plates with
cultured Mu¨ller cells. This procedure was repeated every 48 hours
for 9 consecutive treatments. Control Mu¨ller cells cultures in the
other 6-well plate were subjected only to medium changes in place
of ESMV treatments. To maintain 60% confluence, both treated
and control cells were passaged as needed at the end of an ESMV
treatment. ESMV-exposed and control Mu¨ller cells were exam-
ined after each treatment using the Leica DM IL LED
microscope.
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To evaluate the morphological changes induced by ESMVs at
the completion of each treatment, Mu¨ller cells were fixed in 100%
ethanol for 15 minutes and stained with Harris Hematoxylin and
Eosin Y, dehydrated with serial ethanol washes, air dried and
coverslipped with ProLong Gold antifade reagent. The trans-
mitted light differential interference contrast images were acquired
using the Zeiss Axiovert 135M microscope with a Photometrics
CoolSnap camera. To compare the number of cells present in
ESMV-exposed and control Mu¨ller cell cultures at the end of each
treatment, images of 3–4 fields of view (acquired at 20X
magnification for each well of the 6-well cell culture plates) were
obtained using the Leica DCF295 digital camera. Cells within
each image were individually marked using Adobe Photoshop,
counted, and the treated/control cells ratios were calculated.
At the completion of ESMV treatments, the culture medium of
ESMV-exposed Mu¨ller cells was aspirated; the cells were then
washed 3 times with ample PBS to remove any residual ESMVs
and collected for RNA isolation and gene expression studies.
Mu¨ller cell RNA isolation and Real Time quantitative RT-
PCR
For the initial analysis of gene expression changes in Mu¨ller cells
post-ESMV treatment, total RNA was isolated using the
mirVanaTM miRNA Isolation Kit (Ambion) from the collected
cells and from control cells cultured and from control Mu¨ller cells
cultured under three different conditions (Mu¨ller cells not exposed
to ESMVs, Mu¨ller cells incubated with ESGRO medium
components that remained after ultracentrifugation at 200,000 g
for 3.5 hours, and Mu¨ller cells treated with the components of the
conditioned medium of MEF cultures, after ultracentrifugation at
200,000 g for 3.5 hours). The RNA was quantified and quality
assessed using a Nanodrop ND-1000 spectrophotometer (Thermo
Scientific, Wilmington, DE) and treated with TURBO DNAse
(Ambion) prior to further manipulation. RNA was converted to
cDNA using SuperScriptTM III First-Strand Synthesis SuperMix
for qRT-PCR (Invitrogen). To analyze embryonic gene transfer
from mouse ESMVs to human Mu¨ller cells, mouse-specific primer
pairs described above for Oct4, Sox2, and Nanog were used, and
amplification was detected using Brilliant Sybr Green qPCR
Master Mix (Stratagene, La Jolla, CA) in an Mx3000p qPCR
instrument (Stratagene). All results were normalized to the human
housekeeping gene glyceraldehyde 3-phosphate dehydrogenase
(Gapdh), amplified using commercially available primers (IDT,
Coralville, IA). The relative change in gene expression was
determined using the 22DDCt method of comparative quantifica-
tion. To detect the induction of expression by ESMVs of
endogenous embryonic and early retinal genes in human Mu¨ller
cells, TaqManH primers for the human Oct4, Pax6, and Rax genes
and the TaqmanH Gene Expression Assays protocol and reagents
(Applied Biosystems, Carlsbad, CA) were used; TaqManH Gapdh
primers were used for normalization.
Comparative quantification of mmu-miR-292-3p and mmu-
miR-295 with snRNA U6 (endogenous control) was performed in
3–6 biological samples, ran in parallel, using TaqManH miRNA
qRT-PCR assays and TaqManH probes (Applied Biosystems)
according to manufacturer’s protocol, each primer ran in
triplicate, and the 22DDCt method was used to examine the fold-
change of miRNA levels. The significance of these changes was
assessed using Student’s t-tests. The commercially available primer
sequences for the TaqMan assays can be downloaded from the
manufacturer’s website (https://bioinfo.appliedbiosystems.com/
genome/database/gene/expression.html).
cDNA Microarray Gene Expression Studies
To study the transcriptome changes in Mu¨ller cells in response
to ESMV treatment, control and ESMV-exposed Mu¨ller cells
were collected at 8, 24, and 48 hours post-ESMV treatment (3
independent biological samples for 8 and 24 hours and 2 samples
for 48 hours) and total RNA was isolated from each sample using
the miRNeasy Mini kit for purification of total RNA, including
miRNA (Qiagen, Valencia, CA, USA). The purified RNA samples
were divided into two parts, one to be used for gene expression
array hybridization and the other for miRNA array hybridization.
For gene expression profiling, total RNA samples were reverse
transcribed and each obtained cDNA, in triplicate, was hybridized
to Agilent human 8X60k arrays. Hybridizations were performed
by the UCLA Clinical Microarray Core facility following the
standard Agilent Expression Analysis protocol. The acquisition of
array images was carried out using the Agilent Scan Control and
Feature Extraction 10.7 software. Subsequent raw data were
analyzed using Partek genomics Suite 6.4. Global functional
analyses, network analyses and canonical pathway analyses were
performed using Ingenuity Pathway Analysis (IngenuityH Systems,
www. ingenuity.com). Additionally, to assess the relevance of the
identified gene expression changes, searches for Gene Ontology-
based functional groups overrepresented in the ESMV-treated
cells and literature-based functional networks were performed
using the Database for Annotation, Visualization and Integrated
Discovery (DAVID; http://david.avcc.ncifcrf.gov/ref) online
bioinformatics tool. Identification of enriched categories and
biological processes among regulated genes was performed using
the DAVID Functional Annotation Chart. Only categories with
an enrichment score yielding a p-value ,0.05 were considered
significant.
miRNA Microarray Expression Studies
One mg total RNA samples prepared as described above was
labeled with Hy3TM and the labeled miRNAs were hybridized to
miRNA arrays by the UCLA Clinical Microarray Core facility.
Exiqon miRCURY LNA miRNA arrays (microarrays v11), which
include 927/648/351 human/mouse/rat miRNAs as well as 438
miRPlus miRNAs, were used according to the manufacturer’s
instructions. The miRNA array slides were scanned with an Axon
GenePix 4100A scanner (Molecular Devices, Sunnyvale, CA) and
processed with the GenePix Pro 6.0 software (Molecular Devices).
The raw miRNA data were normalized using a combination of
housekeeping miRNAs and invariant miRNAs. Statistically
different miRNAs were selected using Partek genomic suite 6.4
with thresholds of $3-fold and FDR corrected p,0.05. Individual
miRNAs were studied using the miRBase online database (http://
www.mirbase.org/) and miRNA target prediction analysis was
performed using TargetScan 6.0 software (http://www. targetsca-
n.org/).
Validation of transcript level changes
qRT-PCR analysis of independent samples of ESMV-treated
and control Mu¨ller cells was carried out to validate the expression
changes from the mRNA and miRNA microarray data. Since
microarray analysis indicated that the majority of expression
changes in the genes of interest take place 24 and 48 hours post-
ESMV exposure, these time points were used for array validation.
Total RNA was isolated using miRNeasy Mini kit (Qiagen) and
subjected to on-column DNase digestion per protocol. For gene
expression change validation, RNA was converted to cDNA as
described above, and qPCR was carried out using the following
TaqManH primers, selected to span exon-exon junctions to
eliminate potential genomic DNA amplification in the Expression
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Assay protocol (Applied Biosystems, https://products.
appliedbiosystems.com/ab/en/US/adirect/ab?cmd= catNavi-
gat2&catID= 601803): BMP7, IL6, MMP3, IGF2, Cyclin D2,
Aggrecan, and GFAP, with Gapdh serving as the endogenous
control. In each experiment, a sample without reverse transcrip-
tase and a sample without template were included to demonstrate
specificity and lack of DNA contamination.
For miRNA array validation the following TaqManH miRNA
assays (Applied Biosystems, link above) were used in accordance
with manufacturer’s protocol: hsa-miR-146a, hsa-miR133a, mmu-
miR-294, hsa-miR-199-5p, hsa-miR-214*, hsa-miR-143, normal-
ized against snRNA U6. Fold-change in gene expression was
calculated using the 22DDCt method for each mRNA and miRNA
tested; 3 biological replicates were ran in parallel for each sample
and each primer was ran in triplicate. Student’s t-test was used to
assess significance of gene expression change.
Immunocytochemistry
To investigate which retinal cell-specific markers were expressed
in ESMV-treated and control Mu¨ller cells, the Mu¨ller cells that
had had 8 treatments with ESMVs were seeded on poly-D-lysine-
coated glass coverslips placed in the 6-well culture plates, allowed
to attach, and treated with ESMVs derived from 6 T175 flasks, as
described previously. 24 hours later, ESMV-treated and control
cells were rinsed in 0.1 M PBS and fixed for 30 minutes in 4%
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA),
then rinsed in 0.1 M PBS and blocked in 10% serum containing
1% bovine serum albumin (BSA) and 0.5% Triton X-100 for
1 hour at room temperature. Primary and secondary antibodies
were diluted with PBS containing 3% serum, 1% BSA and 0.5%
Triton X-100. Cells were incubated with the following primary
antibodies, overnight, at 4uC: rabbit monoclonal anti-Brn3a
(1:500, Abcam, Cambridge, MA), mouse anti-Neuronal Nuclei
(NeuN) monoclonal antibody (1:500, Millipore) mouse anti-HPC1
(Syntaxin 1a) monoclonal antibody (1:1000, Sigma, St Louis,
MO), mouse anti-glutamic acid decarboxylase 67 (GAD67)
monoclonal antibody (1:1000, Millipore), mouse anti-1D4 (rho-
dopsin) monoclonal antibody (1:10,000, Millipore), rabbit anti-GS
polyclonal antibody (1:1000, Sigma), mouse anti-parvalbumin
monoclonal antibody (1:1000, Swant, Marly, Switzerland) and
guinea pig anti-vesicular glutamate transporter 2 (vGluT2)
(1:10,000, Millipore). ESMV-treated and control cells were then
incubated for 1 to 2 hours at room temperature with the
appropriate secondary antibodies conjugated to AlexaFluor488,
AlexaFluor568, or AlexaFluor594 (Molecular Probes, Eugene,
OR) and diluted 1:1000. Coverslips were mounted on slides using
ProLongH Gold Antifade Reagent containing the nuclear coun-
terstain DAPI (4,6-diamidino-2-phenylindole; Invitrogen), allowed
to dry, and images were obtained with an Olympus FluoView
FV1000 confocal laser scanning microscope using Olympus
FluoView software for capture and processing (Olympus America,
Center Valley, PA).
Supporting Information
Table S1 Gene Ontology (GO) analysis of the 1894 genes
that were differentially expressed in ESMV-treated vs.
control Mu¨ller cells at all three time points tested by
microarray analysis, grouped by functional category.
(DOC)
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